Castle Biosciences
$19.69
48
-$0.46-2.28% Tuesday 20:00
Statistics
Day High
20.12
Day Low
19.55
52W High
43.04
52W Low
14.65
Volume
458,247
Avg. Volume
-
Mkt Cap
574.73M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
10AugExpected
Expected EPS
-0.396875
Actual EPS
N/A
Financials
5.49%Profit Margin
Profitable664.14MRevenue
36.49MNet Income
Analyst Ratings
44.4Average Price Target
The highest estimate is 52.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CSTL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap15.77B
Myriad Genetics
MYGN
Mkt Cap360.79M
Fulgent Genetics
FLGT
Mkt Cap485.93M
Qiagen NV
QGEN
Mkt Cap7.25B
Pacific Biosciences of California
PACB
Mkt Cap378.93M
Illumina
ILMN
Mkt Cap21.85B
About
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Show more...
CEO
Mr. Derek J. Maetzold
Employees
784
Country
United States
ISIN
US14843C1053
Listings
0 Comments
Share your thoughts
FAQ
What is Castle Biosciences stock price today?▼
The current price of CSTL is $19.69 USD — it has decreased by -2.28% in the past 24 hours. Watch Castle Biosciences stock price performance more closely on the chart.
What is Castle Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Castle Biosciences stocks are traded under the ticker CSTL.
Is Castle Biosciences stock price growing?▼
CSTL stock has fallen by -1.7% compared to the previous week, the month change is a -21.18% fall, over the last year Castle Biosciences has showed a +24.62% increase.
What is Castle Biosciences market cap?▼
Today Castle Biosciences has the market capitalization of 574.73M
When is the next Castle Biosciences earnings date?▼
Castle Biosciences is going to release the next earnings report on August 10, 2026.
What were Castle Biosciences earnings last quarter?▼
CSTL earnings for the last quarter are -0.49 USD per share, whereas the estimation was -0.49 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Castle Biosciences revenue for the last year?▼
Castle Biosciences revenue for the last year amounts to 664.14M USD.
What is Castle Biosciences net income for the last year?▼
CSTL net income for the last year is 36.49M USD.
How many employees does Castle Biosciences have?▼
As of May 27, 2026, the company has 784 employees.
In which sector is Castle Biosciences located?▼
Castle Biosciences operates in the Health & Wellness sector.
When did Castle Biosciences complete a stock split?▼
Castle Biosciences has not had any recent stock splits.
Where is Castle Biosciences headquartered?▼
Castle Biosciences is headquartered in Friendswood, United States.